Cure My Disease

Don't miss your cure!

 Log in / Sign up

Green tea compound EGCG put to the test for clearer, more hydrated skin

NCT ID NCT07725900

Completed Symptom relief Sponsor: Naniek Widyaningrum Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This large-scale trial is testing whether a topical cream containing epigallocatechin gallate (EGCG), a compound from green tea, can reduce facial redness (erythema), dark spots (melanin), and improve skin moisture. Over 300 participants will apply the cream twice daily for 84 days, while a smaller control group receives no product. Researchers will measure changes using specialized skin sensors to see if the cream delivers visible improvements.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a topical skincare cream containing epigallocatechin gallate (EGCG) from green tea
What this could lead to
If effective, this cream could offer a natural, over-the-counter option for reducing facial redness, dark spots, and improving skin hydration.
What could go wrong
This is an early-to-mid-stage trial with a quasi-experimental design, not a randomized controlled trial. Results may not generalize, and individual skin reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Erythema Hyperpigmentation hyperpigmentation of the skin

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY SKIN ERYTHEMA HYPERPIGMENTATION

Contacts and locations

Locations

  • Universitas Islam Sultan Agung

    Semarang, Central Java, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.